Brain Implant Detects Cancer in First 3 Human Patients

Three people in Australia just became the first humans to have a brain implant that can detect and fight cancer placed in their heads.

San Francisco startup Coherence Neuro tested its coin-sized implant during brain tumor removal surgeries at Royal Melbourne Hospital. The device stayed in place for about 30 minutes, giving researchers crucial safety data before moving forward with permanent implants.

The technology works by sensing the unique electrical signals that tumors give off and delivering mild electrical stimulation to stop their growth. Scientists have long known that cancerous tissue behaves differently electrically than healthy brain tissue, similar to how epilepsy and depression affect brain signals.

The implant targets glioblastoma, one of the most aggressive brain cancers. Most patients diagnosed with this cancer live just 15 to 18 months, with fewer than 10 percent surviving five years.

Right now, glioblastoma patients rely on MRI scans every two to three months to monitor their tumors. But brain cancer can become aggressive quickly, and doctors often miss critical changes between scans.

The Coherence device would monitor patients continuously and deliver customized electrical therapy in real time. A connected app lets patients log symptoms while doctors track disease progression and adjust treatment remotely.

The idea builds on existing research. Stanford scientists found in 2019 that aggressive brain tumors grow by forming connections with healthy neurons. When researchers blocked these electrical signals in mice using seizure medication, tumor growth slowed.

A similar wearable device called Optune already helps glioblastoma patients live several months longer. But people must shave their heads, wear adhesive patches on their scalp, and carry batteries in a backpack all day.

The Coherence implant sits inside the skull with 16 thin threads extending into brain tissue. Surgeons would place it during the initial tumor removal surgery to help prevent cancer from returning.

The Bright Side

This approach represents a shift in how we think about treating cancer. Instead of relying solely on chemotherapy and radiation, doctors could use the body's own electrical signals to fight disease. The implant could catch tumor regrowth early and alert doctors to intervene with surgery before a scheduled MRI would even detect the problem.

The company plans to begin trials next year where glioblastoma patients will have the device permanently implanted. For people facing one of medicine's toughest diagnoses, this technology offers something precious: hope backed by science.